|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current assets: | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Short-term investments | |||||||||||||||||||
| Accounts receivable, net | |||||||||||||||||||
| Inventories | |||||||||||||||||||
| Prepaid expenses | |||||||||||||||||||
| Prepaid expenses and assets held for sale | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Property, plant and equipment, net of accumulated depreciation of $3,764 and $3,727 | |||||||||||||||||||
| Intangible assets, net | |||||||||||||||||||
| Goodwill | |||||||||||||||||||
| Intangible assets, net of accumulated amortization of $367 and $354 | |||||||||||||||||||
| Total intangible assets, net | |||||||||||||||||||
| Other non-current assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Liabilities and stockholders’ equity | |||||||||||||||||||
| Current liabilities: | |||||||||||||||||||
| Short-term borrowings | |||||||||||||||||||
| Accounts payable and accrued liabilities | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Total accounts payable and accrued liabilities | |||||||||||||||||||
| Accrued liabilities and liabilities held for sale | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Long-term debt | |||||||||||||||||||
| Other non-current liabilities | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Share-based payments subject to redemption | |||||||||||||||||||
| Redeemable non-controlling interests | |||||||||||||||||||
| Ingredion stockholders’ equity: | |||||||||||||||||||
| Preferred stock — authorized 25.0 shares — $0.01 par value, none issued | |||||||||||||||||||
| Common stock — authorized 200.0 shares — $0.01 par value, 77.8 shares issued at June 30, 2026 and December 31, 2025 | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Less: Treasury stock (common stock: 14.7 and 14.8 shares at June 30, 2026 and December 31, 2025) at cost | |||||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||
| Retained earnings | |||||||||||||||||||
| Total Ingredion stockholders’ equity | |||||||||||||||||||
| Non-redeemable non-controlling interests | |||||||||||||||||||
| Total stockholders’ equity | |||||||||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||||||||
Loading...
